All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional
Intermittent ibrutinib in chronic lymphocytic leukemia
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Karolinska University Hospital
Enrolment target
50
Start
08 Nov 2023
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (2)
- —Sweden
- —Norway
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.